Dr. Paritosh Kafle, MD

Dr. Kafle practices at INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma.

Dr. Kafle's NPI, 1598117913, was assigned on July 9, 2016. Dr. Kafle holds Louisiana license 337822.

Dr. Kafle's primary practice is INTEGRIS Health Miami Hospital - Mammography, at 200 2nd Ave SW, Miami, OK 74354. The practice phone is (918) 540-7551.

Dr. Kafle's primary practice is INTEGRIS Health Miami Hospital - Mammography in Miami, Oklahoma. Dr. Kafle is also affiliated with Thibodaux Regional Health System. The medical group on file is Cardiovascular Institute of the South. Dmand AI also links Dr. Kafle to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kafle practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kafle's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kafle is licensed in Louisiana.

CMS data shows 677 Medicare services from Dr. Kafle across 9 procedure codes in 2024, for 325 Medicare patients. Medicare paid $43,750 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 325 Medicare patients who saw Dr. Kafle in 2024. The largest group is 75 to 84, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kafle's median patient age at 66, with 52% women.

In 2024, Dr. Kafle wrote 349 Medicare Part D claims for 86 patients. 77% of them were for generic drugs. CMS names the drug for 273 of them, across 14 drugs with 11 or more claims each, at $25,058 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

Dr. Kafle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 37 general payments to Dr. Kafle from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 93% of the total. Abiomed paid the most, $322.